Mahi Lakshmi Ashwath
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mahi Lakshmi Ashwath has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Mayuresh Chaudhari
UT Health Sciences Centre, Glen Biggs Institute, San Antonio, TX 78229, USA
3 shared publications Corina Iorgoveanu
2 shared publications- Grace Alexander
Department of Medicine University of Iowa Hospitals & Clinics Iowa City Iowa USA
2 shared publications Ahmad R. Jabri
Heart and Vascular Center, MetroHealth Medical Center, Case Western Reserve University, Cleveland, OH
1 shared publicationAhmed Zaghloul
Division of Cardiovascular Medicine, University of Iowa Hospitals and Clinics, University of Iowa Health Care, Iowa City, USA
1 shared publication- Aiswarya Pillai1 shared publication
Latest Publications
- Open Access
- 9 February 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (4) , 1358
Advanced Cardiac Imaging for Risk Prediction of Pacing-Induced Cardiomyopathy: A Narrative Literature Review
Background/Objective: Pacing-induced cardiomyopathy (PICM) is a common complication of right ventricular (RV) pacing, affecting 6–25% of patients with frequent RV pacing, due to electrical and mechanical dyssynchrony. Certain clinical and electrocardiographic risk factors have been identified, including high RV-pacing burden and longer paced QRS, but their ability to predict the development PICM remains limited. Additionally, other forms of PICM have been described, including heart failure with preserved ejection fraction and RV failure. The goal of this narrative review is to summarize the current evidence utilizing noninvasive imaging to identify patients predisposed to a high risk of PICM. Methods: Using a literature search in the PubMed, Scopus, Google Scholar, and the Cochrane databases from 2000 to 2025, which included but was not limited to the keywords right ventricular pacing, pacemaker-related cardiomyopathy, pacemaker-induced cardiomyopathy, biventricular pacing, conduction system pacing, His bundle pacing, left bundle pacing, echocardiography, computed tomography imaging, and cardiac magnetic resonance imaging, we reviewed randomized control trials, observational retrospective and prospective cohort studies, societal guidelines, and systematic review articles. Conclusions: Essential in the diagnosis of PICM, cardiac imaging can identify patients at risk, even before left ventricular (LV) dysfunction or symptoms develop. Pre- and early post-implantation 2- and 3-dimensional echocardiography with global longitudinal strain provides sensitive parameters for the potential development of PICM. Relative indices of contractile asymmetry have been described. Cardiac magnetic resonance imaging offers an accurate assessment of cardiac volumes and LV synchrony and can also quantify myocardial fibrosis, a significant predictor of PICM. Performing pre-device implantation imaging may help predict subsequent heart failure development and potentially can guide pacing modality selection that can mitigate this risk. Thus, an imaging-guided framework will advance the management of PICM.
- 9 February 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (4) , 1358
Open AccessAdvanced Cardiac Imaging for Risk Prediction of Pacing-Induced Cardiomyopathy: A Narrative Literature Review
Background/Objective: Pacing-induced cardiomyopathy (PICM) is a common complication of right ventricular (RV) pacing, affecting 6–25% of patients with frequent RV pacing, due to electrical and mechanical dyssynchrony. Certain clinical and electrocardiographic risk factors have been identified, including high RV-pacing burden and longer paced QRS, but their ability to predict the development PICM remains limited. Additionally, other forms of PICM have been described, including heart failure with preserved ejection fraction and RV failure. The goal of this narrative review is to summarize the current evidence utilizing noninvasive imaging to identify patients predisposed to a high risk of PICM. Methods: Using a literature search in the PubMed, Scopus, Google Scholar, and the Cochrane databases from 2000 to 2025, which included but was not limited to the keywords right ventricular pacing, pacemaker-related cardiomyopathy, pacemaker-induced cardiomyopathy, biventricular pacing, conduction system pacing, His bundle pacing, left bundle pacing, echocardiography, computed tomography imaging, and cardiac magnetic resonance imaging, we reviewed randomized control trials, observational retrospective and prospective cohort studies, societal guidelines, and systematic review articles. Conclusions: Essential in the diagnosis of PICM, cardiac imaging can identify patients at risk, even before left ventricular (LV) dysfunction or symptoms develop. Pre- and early post-implantation 2- and 3-dimensional echocardiography with global longitudinal strain provides sensitive parameters for the potential development of PICM. Relative indices of contractile asymmetry have been described. Cardiac magnetic resonance imaging offers an accurate assessment of cardiac volumes and LV synchrony and can also quantify myocardial fibrosis, a significant predictor of PICM. Performing pre-device implantation imaging may help predict subsequent heart failure development and potentially can guide pacing modality selection that can mitigate this risk. Thus, an imaging-guided framework will advance the management of PICM.
- Open Access
- 25 December 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (1) , 163
Multimodality Imaging in Cardiac Amyloidosis
Cardiac amyloidosis is an underdiagnosed cause of heart failure characterized by extracellular deposition of misfolded proteins. Advances in non-invasive imaging, including echocardiography, cardiac magnetic resonance imaging (CMR), and radionuclide imaging, have significantly enhanced the diagnostic accuracy and monitoring of cardiac amyloidosis. This review explores the role of each modality, their individual strengths, and current consensus recommendations. Emphasis is placed on the integration of multimodal imaging to guide diagnosis, prognosis, and therapeutic decisions in both AL and ATTR amyloidosis.
- 25 December 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (1) , 163
Open AccessMultimodality Imaging in Cardiac Amyloidosis
Cardiac amyloidosis is an underdiagnosed cause of heart failure characterized by extracellular deposition of misfolded proteins. Advances in non-invasive imaging, including echocardiography, cardiac magnetic resonance imaging (CMR), and radionuclide imaging, have significantly enhanced the diagnostic accuracy and monitoring of cardiac amyloidosis. This review explores the role of each modality, their individual strengths, and current consensus recommendations. Emphasis is placed on the integration of multimodal imaging to guide diagnosis, prognosis, and therapeutic decisions in both AL and ATTR amyloidosis.
- Open Access
- 15 July 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (14) , 5002
Cardiac Imaging in the Diagnosis and Management of Heart Failure
Heart failure (HF) is a complex clinical syndrome that results from any structural or functional impairment of ventricular filling or ejection of blood. The etiology of heart failure is multifactorial, encompassing ischemic heart disease, hypertension, valvular disorders, cardiomyopathies, and metabolic and infiltrative diseases. Despite advances in pharmacologic and device-based therapies, heart failure continues to carry a substantial burden of morbidity, mortality, and healthcare utilization. With the advancement and increased accessibility of cardiac imaging modalities, the diagnostic accuracy for identifying the underlying etiologies of nonischemic cardiomyopathy has significantly improved, allowing for more precise classification and tailored management strategies. This review aims to provide a comprehensive analysis of the current understanding of heart failure, encompassing epidemiology, etiological factors, with a specific focus on diagnostic imaging modalities including the role of echocardiography and strain imaging, cardiac magnetic resonance imaging (CMR), cardiac computed tomography (CT), and nuclear positron emission tomography (PET) imaging and recent advances in the diagnosis and management of heart failure.
- 15 July 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (14) , 5002
Open AccessCardiac Imaging in the Diagnosis and Management of Heart Failure
Heart failure (HF) is a complex clinical syndrome that results from any structural or functional impairment of ventricular filling or ejection of blood. The etiology of heart failure is multifactorial, encompassing ischemic heart disease, hypertension, valvular disorders, cardiomyopathies, and metabolic and infiltrative diseases. Despite advances in pharmacologic and device-based therapies, heart failure continues to carry a substantial burden of morbidity, mortality, and healthcare utilization. With the advancement and increased accessibility of cardiac imaging modalities, the diagnostic accuracy for identifying the underlying etiologies of nonischemic cardiomyopathy has significantly improved, allowing for more precise classification and tailored management strategies. This review aims to provide a comprehensive analysis of the current understanding of heart failure, encompassing epidemiology, etiological factors, with a specific focus on diagnostic imaging modalities including the role of echocardiography and strain imaging, cardiac magnetic resonance imaging (CMR), cardiac computed tomography (CT), and nuclear positron emission tomography (PET) imaging and recent advances in the diagnosis and management of heart failure.
- Open Access
- 28 March 2025
- Published by IntechOpen
Imaging in Myocarditis and Pericarditis
Myocarditis and pericarditis represent inflammatory conditions of cardiac tissue. A variety of etiologies can result in myocarditis and pericarditis, including inflammatory and infectious causes. This chapter aims to provide a detailed overview of the various diagnostic methods for these conditions, focusing on the utility of imaging tests—echocardiography, cardiac CT, 18F FDG-PET, and CMR in the diagnostic work-up, utility, diagnostic features, and limitations of the various modalities. The role of imaging in the diagnosis of recurrent pericarditis and chronic constrictive pericarditis is discussed in this chapter. A brief overview of the management of myocarditis and pericarditis is also presented.
- 28 March 2025
- Published by IntechOpen
Open AccessImaging in Myocarditis and Pericarditis
Myocarditis and pericarditis represent inflammatory conditions of cardiac tissue. A variety of etiologies can result in myocarditis and pericarditis, including inflammatory and infectious causes. This chapter aims to provide a detailed overview of the various diagnostic methods for these conditions, focusing on the utility of imaging tests—echocardiography, cardiac CT, 18F FDG-PET, and CMR in the diagnostic work-up, utility, diagnostic features, and limitations of the various modalities. The role of imaging in the diagnosis of recurrent pericarditis and chronic constrictive pericarditis is discussed in this chapter. A brief overview of the management of myocarditis and pericarditis is also presented.
- Open Access
- 2 May 2024
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 8 (5) , ytae240
A case report of superior vena cava/right coronary artery fistula secondary to chronic endocarditis
Background: Coronary arteriovenous fistulas present an abnormal connection between the coronary arteries and an adjacent systemic or pulmonary vessel. They are rare, representing 0.002% of the general population. The majority is congenital but may additionally occur related to trauma or interventional cardiac procedures. Case summary: We present the case of a 48-year-old male with a history of untreated bacterial endocarditis developing a right coronary/superior vena cava fistula. We detail the imaging findings of this rare phenomenon to arrive at this diagnosis. We describe his clinical course and the interventions considered, including surgical extraction. Unfortunately, this patient left against medical advice before completing recommended treatment. Discussion: We present the first documentation of a right coronary/superior vena cava fistula secondary to chronic untreated bacterial endocarditis. Clinicians should be aware of this rare complication.
- 2 May 2024
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 8 (5) , ytae240
Open AccessA case report of superior vena cava/right coronary artery fistula secondary to chronic endocarditis
Background: Coronary arteriovenous fistulas present an abnormal connection between the coronary arteries and an adjacent systemic or pulmonary vessel. They are rare, representing 0.002% of the general population. The majority is congenital but may additionally occur related to trauma or interventional cardiac procedures. Case summary: We present the case of a 48-year-old male with a history of untreated bacterial endocarditis developing a right coronary/superior vena cava fistula. We detail the imaging findings of this rare phenomenon to arrive at this diagnosis. We describe his clinical course and the interventions considered, including surgical extraction. Unfortunately, this patient left against medical advice before completing recommended treatment. Discussion: We present the first documentation of a right coronary/superior vena cava fistula secondary to chronic untreated bacterial endocarditis. Clinicians should be aware of this rare complication.
- Open Access
- 21 February 2024
- Published by IntechOpen
State of the Art and New Advances: Cardiac MRI
Cardiac Magnetic Resonance Imaging (CMR) is an advanced imaging modality for better assessment of cardiac structure, function and tissue characterization. This is an essential imaging modality when indicated for assessment of a variety of cardiomyopathies, cardiac ischemia, myocardial viability, arrhythmias, cardiac masses, congenital heart disease, shunts, acute and constrictive pericardial diseases among others. CMR is sometimes referred to as the non-invasive biopsy given the significant information it provides. This chapter discusses the current state of the art of CMR with discussion about the indications, common sequences used, and the role of CMR in evaluation of ischemic and non-ischemic cardiac disease. This chapter also discusses new advances and the future of the field of CMR.
- 21 February 2024
- Published by IntechOpen
Open AccessState of the Art and New Advances: Cardiac MRI
Cardiac Magnetic Resonance Imaging (CMR) is an advanced imaging modality for better assessment of cardiac structure, function and tissue characterization. This is an essential imaging modality when indicated for assessment of a variety of cardiomyopathies, cardiac ischemia, myocardial viability, arrhythmias, cardiac masses, congenital heart disease, shunts, acute and constrictive pericardial diseases among others. CMR is sometimes referred to as the non-invasive biopsy given the significant information it provides. This chapter discusses the current state of the art of CMR with discussion about the indications, common sequences used, and the role of CMR in evaluation of ischemic and non-ischemic cardiac disease. This chapter also discusses new advances and the future of the field of CMR.
- Open Access
- 21 December 2023
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 8 (1) , ytad636
Cardiac pseudoaneurysms: a clinical case series
Background: Cardiac pseudoaneurysms are a potentially life-threatening pathology with a variety of non-specific clinical manifestations. This case series uniquely shares a collection of rare pathologies with differing preceding risk factors and presentations, with an emphasis on the utility of multi-modality imaging in diagnosis and management. Case summary: We present three cases of cardiac pseudoaneurysms. Case 1 is a 27-year-old woman with delayed presentation of a traumatic left ventricular pseudoaneurysm (LVP). Case 2 is a 73-year-old man with post-myocardial infarction LVP. Case 3 is a 38-year-old man with left ventricular outflow tract pseudoaneurysm after aortic valve replacement. Discussion: Cardiac pseudoaneurysms are rare and important to diagnose in a timely manner. Advances in non-invasive imaging modalities have improved our ability to distinguish pseudoaneurysms from other pathologies, leading to more timely management.
- 21 December 2023
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 8 (1) , ytad636
Open AccessCardiac pseudoaneurysms: a clinical case series
Background: Cardiac pseudoaneurysms are a potentially life-threatening pathology with a variety of non-specific clinical manifestations. This case series uniquely shares a collection of rare pathologies with differing preceding risk factors and presentations, with an emphasis on the utility of multi-modality imaging in diagnosis and management. Case summary: We present three cases of cardiac pseudoaneurysms. Case 1 is a 27-year-old woman with delayed presentation of a traumatic left ventricular pseudoaneurysm (LVP). Case 2 is a 73-year-old man with post-myocardial infarction LVP. Case 3 is a 38-year-old man with left ventricular outflow tract pseudoaneurysm after aortic valve replacement. Discussion: Cardiac pseudoaneurysms are rare and important to diagnose in a timely manner. Advances in non-invasive imaging modalities have improved our ability to distinguish pseudoaneurysms from other pathologies, leading to more timely management.
- 10 February 2023
- Published by Elsevier in Current Problems in Cardiology
- Vol. 48 (6) , 101641
Is Virtual Learning Here to Stay? A Multispecialty Survey of Residents, Fellows, and Faculty
- 10 February 2023
- Published by Elsevier in Current Problems in Cardiology
- Vol. 48 (6) , 101641
Is Virtual Learning Here to Stay? A Multispecialty Survey of Residents, Fellows, and Faculty
- Open Access
- 17 June 2021
- Published by Springer Nature in Heart Failure Reviews
- Vol. 26 (6) , 1287-1296
Peripartum cardiomyopathy: a review
Peripartum cardiomyopathy is a form of idiopathic systolic heart failure which occurs during the end of pregnancy or the early post-partum in the absence of an identifiable etiology. The exact pathogenesis remains unknown, and the incidence is higher in African ancestry, multiparous and hypertensive women, or older maternal age. Delay in diagnosis is common, mainly because symptoms of heart failure mimic those of normal pregnancy. Echocardiography showing decreased myocardial function is at the center of the diagnosis. Management relies on the general guidelines of management of other forms of non-ischemic cardiomyopathy; however, special attention should be paid when choosing medications to ensure fetal safety. Outcomes can be variable and can range from complete recovery to persistent heart failure requiring transplant or even death. High rates of relapse with subsequent pregnancies can occur, especially with incomplete myocardial recovery. Additional research about the etiology, experimental drugs, prognosis, and duration of treatment after recovery are needed.
- 17 June 2021
- Published by Springer Nature in Heart Failure Reviews
- Vol. 26 (6) , 1287-1296
Open AccessPeripartum cardiomyopathy: a review
Peripartum cardiomyopathy is a form of idiopathic systolic heart failure which occurs during the end of pregnancy or the early post-partum in the absence of an identifiable etiology. The exact pathogenesis remains unknown, and the incidence is higher in African ancestry, multiparous and hypertensive women, or older maternal age. Delay in diagnosis is common, mainly because symptoms of heart failure mimic those of normal pregnancy. Echocardiography showing decreased myocardial function is at the center of the diagnosis. Management relies on the general guidelines of management of other forms of non-ischemic cardiomyopathy; however, special attention should be paid when choosing medications to ensure fetal safety. Outcomes can be variable and can range from complete recovery to persistent heart failure requiring transplant or even death. High rates of relapse with subsequent pregnancies can occur, especially with incomplete myocardial recovery. Additional research about the etiology, experimental drugs, prognosis, and duration of treatment after recovery are needed.